MRI Technique Could Reduce Need for Breast Biopsies


Bickelhaupt
Bickelhaupt

Unenhanced diagnostic MRI-diffusion-weighted imaging with background suppression (DWIBS) mammography can help exclude malignancy in women with suspicious X-ray screening mammograms without the use of ionizing radiation or a contrast agent, according to a new study published online in the journal, Radiology). The method has the potential to reduce unnecessary biopsies—as well as emotional distress—for breast cancer screening patients if used as a complement after the regular screening clarification procedure.

Sebastian Bickelhaupt, M.D., of the German Cancer Research Center, Heidelberg, Germany, and colleagues conducted a prospective institutional review that included 50 women (mean age, 57.1 years; range, 50-69 years), who gave informed consent and who had suspicious screening mammograms and an indication for biopsy from September 2014 to January 2015. Before biopsy, full diagnostic contrast-enhanced MR imaging was performed that included DWIBS (b = 1500 sec/mm2). Two abbreviated protocols (APs) based on maximum intensity projections (MIPs) were evaluated regarding the potential to exclude malignancy: DWIBS (AP1) and subtraction images from the first post-contrast and the unenhanced series (AP2). Diagnostic indexes of both methods were examined using the McNemar test and were compared with those of the full diagnostic protocol and histopathologic findings.

Of the 50 participants, 24 (48 percent) had a breast carcinoma. With AP1 (DWIBS), the sensitivity was 0.92 (95 percent confidence interval [CI]:0.73, 0.98), the specificity was 0.94 (95 percent CI: 0.77, 0.99), the negative predictive value (NPV) was 0.92 (95 percent CI: 0.75, 0.99), and the positive predictive value (PPV) was 0.93 (95 percent CI: 0.75, 0.99). The mean reading time was 29.7 seconds (range, 4.9–110.0 seconds) and was less than 3 seconds (range, 1.2–7.6 seconds) in the absence of suspicious findings on the DWIBS MIPs. With the AP2 protocol, the sensitivity was 0.85 (95 percent CI: 0.78, 0.95), the specificity was 0.90 (95 percent CI: 0.72, 0.97), the NPV was 0.87 (95 percent CI: 0.69, 0.95), the PPV was 0.89 (95 percent CI: 0.69, 0.97), and the mean reading time was 29.6 seconds (range, 6.0–100.0 seconds).

Unenhanced diagnostic MR imaging–DWIBS mammography achieved a comparable accuracy to the full diagnostic protocol and to abbreviated contrast-enhanced protocols when used as a complementary method after screening mammography, according to researchers.

“The comprehensive method is fast and robust to perform as a complement to routine mammography. Along with lack of need for intravenous contrast agent administration, ad-vantages include its short acquisition time of less than seven minutes and short reading time of less than 30 seconds,” the authors write.

Figure 1. Images in 65-year-old breast cancer screening participant with a suspicious lesion (arrow) at screening mammography.
Figure 1. Images in 65-year-old breast cancer screening participant with a suspicious lesion (arrow) at screening mammography. (a) Mediolateral oblique screening mammogram. (b) Diffusion-weighted imaging with background suppression (b = 1500 sec/mm2 ) maximum intensity projection, displayed with black-white inversion, shows the lesion as an area of focal diffusion restriction.
Figure 2. Images show example of a screening-detected lesion in a 67-year-old breast cancer screening patient.
Figure 2. Images show example of a screening-detected lesion in a 67-year-old breast cancer screening patient. (a) Diffusion-weighted imaging with background suppression (b = 1500 sec/mm2 ) maximum intensity projection (MIP), displayed with black-white inversion, clear depicts the focal lesion as an area of focal diffusion restriction. (b) First postcontrast subtraction MIP shows an area of subtle enhancement that is partially obscured by generally increased background enhancement.
Figure 3. Images show example of a screening-detected lesion in a 51-year-old breast cancer screening participant
Figure 3. Images show example of a screening-detected lesion in a 51-year-old breast cancer screening participant who was examined with breast MR imaging protocols that revealed a second lesion on the diffusion-weighted imaging with background suppression maximum intensity projection. 

Web Extras